Intrinsic Value of S&P & Nasdaq Contact Us

Neumora Therapeutics, Inc. Common Stock NMRA

NASDAQ Global Select

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.25
+251.9%

Neumora Therapeutics, Inc. Common Stock (NMRA) current share price is $2.06. The gold spot price is $4,825.20 per troy ounce. Using the formula: NMRA in gold = $2.06 × 31.1035 ÷ $4,825.20 = 0.0133 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of NMRA when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding NMRA shares over the measured period.

NMRA in US Dollars
Gold in US Dollars
NMRA in Gold (grams per share)

Real Wealth Growth Rate

NMRA
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{NMRA}_{\text{gold}}(t) = \frac{P_{\text{NMRA}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{NMRA}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{NMRA}_{\text{gold}}^{(T)}}{\text{NMRA}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{NMRA}_\text{gold}^{(0)}$ = initial gold-price, $\text{NMRA}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ALMS
ALMS
Alumis Inc. Common Stock
$24.16
+5.55%
RAPT
RAPT
RAPT Therapeutics, Inc.
$58.01
+0.00%
OMER
OMER
Omeros Corporation
$12.25
+3.46%
LXRX
LXRX
Lexicon Pharmaceuticals, Inc.
$1.86
+6.29%
PRTA
PRTA
Prothena Corporation plc
$10.82
+1.98%
ADCT
ADCT
ADC Therapeutics S.A.
$4.37
+13.21%
FDMT
FDMT
4D Molecular Therapeutics, Inc.
$9.77
+1.14%
FULC
FULC
Fulcrum Therapeutics, Inc.
$8.25
+4.43%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message